Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in LLY — ELI LILLY & Co

CIK 720005 ST. PETERSBURG, FL
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,055,643,274
+$560,414,577 QoQ
Shares Held
1,713,850
+5.4% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#52
of 4,632 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 7% Shared 0% None 93%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$1,199,430
CallShares
1,000
PutValue
$959,544
PutShares
800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $10,536,270,733 across 17 Drug Manufacturers - General names. LLY ranks #3 (19.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
 10,410,159 $2,619,612,407
2 JNJ
Johnson & Johnson
 10,114,310 $2,568,731,308
3 LLY
ELI LILLY & Co
This page 		1,713,850 $2,055,643,274
4 MRK
Merck & Co., Inc.
 6,236,773 $801,425,329
5 AMGN
Amgen Inc
 1,602,419 $580,267,967
6 AZN
Astrazeneca PLC
 2,409,624 $456,912,900
7 GILD
Gilead Sciences, Inc.
 2,436,019 $307,766,638
8 PFE
Pfizer Inc
 11,942,054 $287,564,657

All Filings in LLY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $959,544 800
2026-06-30 $1,199,430 1,000
2026-06-30 $2,055,643,274 1,713,850
2026-03-31 $919,770 1,000
2026-03-31 $1,563,609 1,700
2026-03-31 $1,495,228,697 1,625,655
2025-12-31 $1,601,228,210 1,489,958
2025-12-31 $322,404 300
2025-09-30 $1,053,488,597 1,380,719
2025-06-30 $1,162,962,874 1,491,877
2025-03-31 $1,215,092,004 1,471,216
2024-12-31 $1,240,651,864 1,607,062